pro drug
Showing 1 - 25 of >10,000
Blood Pressure, Diabetes, Obesity Trial in Kansas City (Hydrochlorothiazide 12.5Mg Tab, Clonidine Pill, Placebo)
Recruiting
- Blood Pressure
- +5 more
- Hydrochlorothiazide 12.5Mg Tab
- +2 more
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 15, 2022
Opioid Use Disorder Trial in Miami (PROCare)
Recruiting
- Opioid Use Disorder
- PROCare
-
Miami, FloridaSouth Florida Behavioral Health Network, Inc.
Mar 6, 2022
Artery Disease Trial in France (endovascular intervention)
Not yet recruiting
- Artery Disease
- endovascular intervention
-
Avignon, France
- +5 more
Jun 5, 2023
Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)
Active, not recruiting
- Tachycardia
- Chronic Orthostatic Intolerance
- Acetazolamide
- +22 more
-
Nashville, TennesseeVanderbilt University Autonomic Dysfunction Center
Sep 12, 2022
Peripheral Arterial Disease Below The Knee Trial
Not yet recruiting
- Peripheral Arterial Disease Below The Knee
- (no location specified)
Mar 4, 2022
Integrating 4 Measures to Assess Physical Function in Cancer
Recruiting
- Physical Function
- +5 more
- PRO Instruments assessment questionnaire
- +4 more
-
New Haven, Connecticut
- +1 more
Feb 7, 2022
Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Abemaciclib
- Trastuzumab Emtansine
-
Yuma, Arizona
- +5 more
May 25, 2022
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial
Recruiting
- Metastatic Salivary Gland Carcinoma
- +4 more
- Docetaxel
- +3 more
-
New York, New YorkMemorial Sloane Kettering Cancer Center
Jan 11, 2023
HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,
Completed
- HER2 Positive Breast Carcinoma
- +6 more
- Utomilumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 22, 2022
Diabetic Foot Ulcers Trial in Dallas (Cardinal Pro +Simultaneous Irrigation (NPWTi), Cardinal Pro (NPWT) Therapy)
Completed
- Diabetic Foot Ulcers
- Cardinal Pro +Simultaneous Irrigation (NPWTi)
- Cardinal Pro (NPWT) Therapy
-
Dallas, TexasUT Southwestern Medical Center at Dallas
Aug 12, 2020
Stable Angina, Ischemic Heart Disease, Coronary Artery Disease Trial (Provisional DCB approach PCI procedure, Standard
Not yet recruiting
- Stable Angina
- +4 more
- Provisional DCB approach PCI procedure
- Standard provisional approach PCI procedure
- (no location specified)
May 23, 2020
Healthy Trial in Gainesville (TR-700 (active moiety), TR-701 (pro-drug))
Completed
- Healthy
- TR-700 (active moiety)
- TR-701 (pro-drug)
-
Gainesville, FloridaGeneral Clinical Research Center
Nov 13, 2019
Cardiac Surgery, CAD, Valve Heart Disease Trial in Ioannina (Protamin)
Recruiting
- Cardiac Surgery
- +3 more
-
Ioannina, Epirus, GreeceUniversity Hospital of Ioannina
Nov 29, 2023
Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)
Recruiting
- Healthy
- Psilocybin
- +2 more
-
Zürich, SwitzerlandPsychiatrische Universitätsklinik Zürich
Oct 3, 2023
Essential Pro PMCF Study ( rEPIC04E )
Recruiting
- Coronary Artery Disease (CAD)
- Ischemic Heart Disease
- Essential pro
-
Algeciras, Spain
- +6 more
Nov 30, 2022
Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast
Completed
- Premenopausal Breast Cancer
- Leuprorelin acetate
-
Tokyo, JapanTakeda selected site
Oct 9, 2019
CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at
Withdrawn
- CCR5
- +3 more
- 700mg leronlimab weekly dose
- +3 more
- (no location specified)
Feb 15, 2023
Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)
Recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab
- +4 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
Not yet recruiting
- Post-Operative Complications in Cardiac Surgery
- RBT-1
- Placebo
- (no location specified)
Oct 16, 2023
Wrinkle, Acne Scars, Benign Epidermal Pigmented Lesions Trial in Sacramento, Westford (PicoSure Pro Device, PicoSure Device,
Active, not recruiting
- Wrinkle
- +4 more
- PicoSure Pro Device
- +2 more
-
Sacramento, California
- +1 more
Sep 9, 2022
Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet
Recruiting
- Gastroesophageal Reflux Disease
- Fexuprazan Hydrochloride
-
Busan, Korea, Republic ofCo&Ping Otolaryngology Clinic
May 24, 2023
Determine Pro-Inflammatory Cytokine Kinetics During Immune
Not yet recruiting
- Non Small Cell Lung Cancer
- Melanoma
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jan 30, 2023
Chronic Kidney Failure in Children and Young Adults Trial (Dapagliflozin, Placebo)
Not yet recruiting
- Chronic Kidney Failure in Children and Young Adults
- Dapagliflozin
- Placebo
- (no location specified)
Jul 10, 2023